Terms: = Lung cancer AND GPC3, OCI-5, 2719, ENSG00000147257, SGBS, SGB, DGSX, SDYS, P51654, AC002420_1, SGBS1 AND Diagnosis
9 results:
1. Clinicopathological features and differential diagnosis of gastric metastases.
Chen W; Liu C; Liu Y; Yuan J; Wang Z
World J Surg Oncol; 2023 Aug; 21(1):258. PubMed ID: 37608278
[TBL] [Abstract] [Full Text] [Related]
2. Silicosis, asbestosis, and pulmonary fibrosis in Ontario, Canada from 1996 to 2019.
Zhang Y; Rajaram N; Lau A; Mehta K; Holness DL; Tarlo SM; Arrandale VH
Am J Ind Med; 2023 Aug; 66(8):670-678. PubMed ID: 37302125
[TBL] [Abstract] [Full Text] [Related]
3. Trends in Survival Rates of Non-Small Cell lung cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
[TBL] [Abstract] [Full Text] [Related]
4. Discovery of potential biomarkers for lung cancer classification based on human proteome microarrays using Stochastic Gradient Boosting approach.
Yao N; Pan J; Chen X; Li P; Li Y; Wang Z; Yao T; Qian L; Yi D; Wu Y
J Cancer Res Clin Oncol; 2023 Aug; 149(10):6803-6812. PubMed ID: 36807761
[TBL] [Abstract] [Full Text] [Related]
5. Clinicopathological features and differential diagnosis of hepatocellular carcinoma in extrahepatic metastases.
Chen D; Li Z; Song Q; Qian L; Xie B; Zhu J
Medicine (Baltimore); 2018 Dec; 97(50):e13356. PubMed ID: 30557986
[TBL] [Abstract] [Full Text] [Related]
6. Reevaluation of glypican-3 as a serological marker for hepatocellular carcinoma.
Chen M; Li G; Yan J; Lu X; Cui J; Ni Z; Cheng W; Qian G; Zhang J; Tu H
Clin Chim Acta; 2013 Aug; 423():105-11. PubMed ID: 23643963
[TBL] [Abstract] [Full Text] [Related]
7. Arginase-1: a novel immunohistochemical marker of hepatocellular differentiation in fine needle aspiration cytology.
McKnight R; Nassar A; Cohen C; Siddiqui MT
Cancer Cytopathol; 2012 Aug; 120(4):223-9. PubMed ID: 22298472
[TBL] [Abstract] [Full Text] [Related]
8. Glypican-3 as a potential differential diagnosis marker for hepatocellular carcinoma: a tissue microarray-based study.
Zhang L; Liu H; Sun L; Li N; Ding H; Zheng J
Acta Histochem; 2012 Oct; 114(6):547-52. PubMed ID: 22119409
[TBL] [Abstract] [Full Text] [Related]
9. The glypican 3 oncofetal protein is a promising diagnostic marker for hepatocellular carcinoma.
Yamauchi N; Watanabe A; Hishinuma M; Ohashi K; Midorikawa Y; Morishita Y; Niki T; Shibahara J; Mori M; Makuuchi M; Hippo Y; Kodama T; Iwanari H; Aburatani H; Fukayama M
Mod Pathol; 2005 Dec; 18(12):1591-8. PubMed ID: 15920546
[TBL] [Abstract] [Full Text] [Related]